Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis

Plasminogen activator inhibitor type 1 (PAI-1) is an inhibitor of plasmin production. Plasmin can directly or indirectly to degrade cartilage and bone matrix. The PAI-1 Hin dIII polymorphism has been associated with high PAI-1 plasma levels in myocardial infarction patients and control populations....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental medicine 2009-09, Vol.9 (3), p.223-228
Hauptverfasser:	Torres-Carrillo, Norma, Torres-Carrillo, Nora Magdalena, Martínez-Bonilla, Gloria Esther, Vázquez-Del Mercado, Mónica, Palafox-Sánchez, Claudia Azucena, Oregón-Romero, Edith, Bernard-Medina, Ana Guilaisne, Rangel-Villalobos, Héctor, Muñoz-Valle, José Francisco
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis, Rheumatoid - pathology Deoxyribonuclease HindIII - metabolism Disease Susceptibility Enzyme-Linked Immunosorbent Assay - methods Gene Frequency Hematology Humans Internal Medicine Medicine Medicine & Public Health Oncology Original Article Plasma - chemistry Plasminogen Activator Inhibitor 1 - blood Plasminogen Activator Inhibitor 1 - genetics Polymerase Chain Reaction - methods Polymorphism Polymorphism, Genetic Polymorphism, Restriction Fragment Length Protease inhibitors Rheumatoid arthritis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!